| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |